• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Mar 1985; 82(5): 1526–1530.
PMCID: PMC397296

Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

Abstract

Pluripotent hematopoietic colony-stimulating factor (pluripotent CSF), a protein that is constitutively produced by the human bladder carcinoma cell line 5637, has been purified from low serum (0.2% fetal calf serum)-containing conditioned medium. The purification involved sequential ammonium sulfate precipitation, ion-exchange chromatography, gel filtration, and reversed-phase high-performance liquid chromatography. The purified protein has a molecular weight of 18,000 in NaDodSO4/polyacrylamide gel electrophoresis, both by the silver staining technique and by elution of biological activity from a corresponding gel slice, and has an isoelectric point of 5.5. Pluripotent CSF supports the growth of human mixed colonies, granulocyte-macrophage colonies, and early erythroid colonies and induces differentiation of the human promyelocytic leukemic cell line HL-60 and the murine myelomonocytic leukemic cell line WEHI-3B (D+). The specific activity of the purified pluripotent CSF in the granulocyte-macrophage colony assay is 1.5 X 10(8) units/mg of protein.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980 Dec;56(6):947–958. [PubMed]
  • Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem. 1983 Jul 25;258(14):9017–9023. [PubMed]
  • Ihle JN, Keller J, Henderson L, Klein F, Palaszynski E. Procedures for the purification of interleukin 3 to homogeneity. J Immunol. 1982 Dec;129(6):2431–2436. [PubMed]
  • Fung MC, Hapel AJ, Ymer S, Cohen DR, Johnson RM, Campbell HD, Young IG. Molecular cloning of cDNA for murine interleukin-3. Nature. 1984 Jan 19;307(5948):233–237. [PubMed]
  • Gough NM, Gough J, Metcalf D, Kelso A, Grail D, Nicola NA, Burgess AW, Dunn AR. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature. 309(5971):763–767. [PubMed]
  • Nicola NA, Metcalf D, Johnson GR, Burgess AW. Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood. 1979 Sep;54(3):614–627. [PubMed]
  • Wu MC, Yunis AA. Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells. J Clin Invest. 1980 Mar;65(3):772–775. [PMC free article] [PubMed]
  • Golde DW, Bersch N, Quan SG, Lusis AJ. Production of erythroid-potentiating activity by a human T-lymphoblast cell line. Proc Natl Acad Sci U S A. 1980 Jan;77(1):593–596. [PMC free article] [PubMed]
  • Lusis AJ, Quon DH, Golde DW. Purification and characterization of a human T-lymphocyte-derived granulocyte-macrophage colony-stimulating factor. Blood. 1981 Jan;57(1):13–21. [PubMed]
  • Abboud CN, Brennan JK, Barlow GH, Lichtman MA. Hydrophobic adsorption chromatography of colony-stimulating activities and erythroid-enhancing activity from the human monocyte-like cell line, GCT. Blood. 1981 Dec;58(6):1148–1154. [PubMed]
  • Okabe T, Nomura H, Sato N, Ohsawa N. Large-scale preparation and characterization of human colony-stimulating factor. J Cell Physiol. 1982 Jan;110(1):43–49. [PubMed]
  • Das SK, Stanley ER, Guilbert LJ, Forman LW. Human colony-stimulating factor (CSF-1) radioimmunoassay: resolution of three subclasses of human colony-stimulating factors. Blood. 1981 Sep;58(3):630–641. [PubMed]
  • Das SK, Stanley ER. Structure-function studies of a colony stimulating factor (CSF-1). J Biol Chem. 1982 Nov 25;257(22):13679–13684. [PubMed]
  • Motoyoshi K, Suda T, Kusumoto K, Takaku F, Miura Y. Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood. 1982 Dec;60(6):1378–1386. [PubMed]
  • Fauser AA, Messner HA. Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood. 1978 Dec;52(6):1243–1248. [PubMed]
  • Fauser AA, Messner HA. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. Blood. 1979 May;53(5):1023–1027. [PubMed]
  • Messner HA, Izaquirre CA, Jamal N. Identification of T lymphocytes in human mixed hemopoietic colonies. Blood. 1981 Aug;58(2):402–405. [PubMed]
  • Ruppert S, Löhr GW, Fauser AA. Characterization of stimulatory activity for human pluripotent stem cells (CFUGEMM). Exp Hematol. 1983 Feb;11(2):154–161. [PubMed]
  • Fauser AA, Messner HA, Lusis AJ, Golde DW. Stimulatory activity for human pluripotent hemopoietic progenitors produced by a human T-lymphocyte cell line. Stem Cells. 1981;1(2):73–80. [PubMed]
  • Salahuddin SZ, Markham PD, Lindner SG, Gootenberg J, Popovic M, Hemmi H, Sarin PS, Gallo RC. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science. 1984 Feb 17;223(4637):703–707. [PubMed]
  • Broxmeyer HE, Moore MA, Ralph P. Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. Exp Hematol. 1977 Mar;5(2):87–102. [PubMed]
  • Lu L, Broxmeyer HE, Meyers PA, Moore MA, Thaler HT. Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins. Blood. 1983 Feb;61(2):250–256. [PubMed]
  • Lu L, Broxmeyer HE. The selective enhancing influence of hemin and products of human erythrocytes on colony formation by human multipotential (CFUGEMM) and erythroid (BFUE) progenitor cells in vitro. Exp Hematol. 1983 Sep;11(8):721–729. [PubMed]
  • Metcalf D. Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin. Int J Cancer. 1980 Feb 15;25(2):225–233. [PubMed]
  • Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MA. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. J Exp Med. 1982 Aug 1;156(2):454–464. [PMC free article] [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Westbrook CA, Gasson JC, Gerber SE, Selsted ME, Golde DW. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. J Biol Chem. 1984 Aug 25;259(16):9992–9996. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...